Substantial variations in referrals for advanced heart failure therapies are apparent across the UK and Ireland, with no ...

Repairon, a biotechnology company developing regenerative cardiac therapies, today announced that clinical results evaluating its engineered human heart muscle tissue for patients with advanced heart ...

Participants exposed critical gaps in the diagnosis, treatment, and coordination of care for patients with heart failure with preserved ejection fraction and charted a path forward.

Heart failure’s unpredictable trajectory often delays palliative referral; early integration and proactive follow-up can ...

AI-powered platform uses consumer wearables to help clinicians monitor heart failure patients beyond the hospital SANTA CLARA, Calif.--(BUSINESS WIRE ...

Cardiac gene therapy was once viewed as a promising breakthrough before high-profile clinical setbacks dampened expectations. Now, advances in gene delivery, viral vectors and molecular targeting are ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Experts warn that while heart transplants and mechanical support systems are saving lives, lack of awareness and delayed access to specialist care continue to cost many patients precious time.

Germany: Interim findings from an early-stage study suggest that BioVAT, a tissue-engineered cardiac muscle patch therapy, may help remuscularize the heart in patients with advanced heart ...

For millions of people with heart failure, the latest treatment options — including advanced surgical procedures and innovative devices to assist a failing heart — can be game-changing, especially ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. After years of living with advanced heart disease, a ...